Analyst Ratings for CVS Health Corp. (CVS)

Updated: 2017-07-28

Analysts covering CVS Health Corp. (NYSE:CVS) have given it a consensus rating of Overweight. CVS had previously received a consensus rating of Overweight a month ago.

A buy rating was issued by 16 analysts, 1 gave an overweight rating, 8 issued a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Compared to three months ago, there has been an decrease of 1 in the number of analysts with a positive outlook on the stock. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

A number of analysts gave price targets for CVS. The highest price target was 109, which equates to a potential upside of 38.11 percent. The lowest price target was 77, implying potential capital losses of -2.43 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. The average change in earnings estimates over the last 90 days is -0.76 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of 0.17 percent in FY estimates.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, which can be compared to the 0 analysts that decreased their estimates. During this time, 3 analysts made positive revisions in their estimates for this fiscal year's earnings, while 0 analysts decreased their estimates.

CVS has an estimated earnings growth rate of 23.24 percent as forecasted by analysts. People on Wall Street often look at a company's PEG ratio. A lower PEG ratio is favorable, because that is often interpreted as the company being fairly priced relative to its growth rate. Many investors consider PEG ratios between 0 and 1 as preferrable, though it could be better to see where the ratio stands relative to peers in the industry. The PEG ratio of CVS is 0.71.

CVS has traded between a high of 98.66 and a low of 69.30 over the past year. Today's price is 13.88 percent above the 52-week low, and 20.01 percent lower than its 52-week high. CVS has a price/earnings ratio of 16.44. Investors typically compare the P/E ratio to a company's peers in the industry. The CVS value stock report compares CVS to some of its peers using value stock charts. The stock has a market capitalization of $79.76 billion. CVS's next earnings release will be on 0000-00-00, which is days away.